RxDoctor Payments Data

Anne Bates

Psychiatric/Mental Health · Valparaiso, INNPI 1225136047

Payments from drug & device makers

$609in general payments, 2019–2025

Across 33 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$163
  • Johnson & Johnson$149
  • Otsuka America Pharmaceutical, Inc.$128
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$81
  • Neurocrine Biosciences, Inc.$38
  • Sunovion Pharmaceuticals Inc.$37
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$609 in reported general payments places this provider in the 50th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$13,700
Medicare patients
31
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole22$66,205
Invega SustennaPaliperidone Palmitate13$49,902
VraylarCariprazine Hcl22$30,378
Lurasidone Hcl18$8,070
Olanzapine80$1,991
Quetiapine Fumarate97$1,634
Divalproex Sodium ErDivalproex Sodium20$1,601
Armodafinil22$1,417
Atomoxetine Hcl12$1,385
Prazosin Hcl49$1,325
Venlafaxine Hcl ErVenlafaxine Hcl74$1,065
Hydroxyzine Pamoate44$904
Bupropion XlBupropion Hcl42$773
Quetiapine Fumarate ErQuetiapine Fumarate12$756
Mirtazapine39$739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena$128$66,20522 claims
Johnson & JohnsonInvega Sustenna$149$49,90213 claims
AbbVieVraylar$163$30,37822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Valparaiso

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →